Results 201 to 210 of about 80,266 (330)

Különfélék. Az ELTE BTK Magyar Nyelvtudományi és Finnugor Intézete Könyvtárának Magyar nyelvtudományi gyűjteménye, a Nyelvészkönyvtár

, 2016
Mária Faga-Nagy, Jakab Katalin, Gabriella Kiss   +2 more
openalex   +1 more source

BTK Inhibitor [PDF]

, 2020
openaire   +1 more source

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.

New England Journal of Medicine, 2013
J. Byrd, R. Furman, S. Coutre, I. Flinn, J. Burger, K. Blum, B. Grant, J. Sharman, M. Coleman, W. Wierda, Jeffrey A Jones, Weiqiang Zhao, N. Heerema, A. Johnson, J. Sukbuntherng, B. Chang, F. Clow, E. Hedrick, J. Buggy, D. James, S. O'brien   +20 more
semanticscholar   +1 more source

Current State of Evidence for Implant Placement and Loading in Partially Edentulous Patients: A Systematic Review

Clinical Implant Dentistry and Related Research, Volume 28, Issue 1, February 2026.
ABSTRACT Objectives To systematically review the updated evidence for the clinical outcome of fixed implant prostheses treated with different combinations of implant placement and loading protocols in partially edentulous patients. Materials and Methods An electronic search was performed in Medline, Embase, and Central to identify studies of implants ...
German O. Gallucci, Adam Hamilton, Samuel Akhondi, Kevser Pala, Juan Francisco Peña‐Cardelles   +4 more
wiley   +1 more source

Cardiovascular Challenges in Chronic Lymphocytic Leukemia (CLL) Patients Undergoing Bruton Tyrosine Kinase (BTK) Inhibitor Therapy

European Journal of Haematology, Volume 116, Issue 2, Page 104-115, February 2026.
ABSTRACT Background/Objectives Bruton tyrosine kinase inhibitors (BTKis) have revolutionized treatment for chronic lymphocytic leukemia (CLL), but cardiovascular (CV) toxicities pose significant challenges. Second‐generation BTKis offer improved target specificity, yet CV risks persist.
Stefano Oliva, Stefano Molica
wiley   +1 more source

Kinase-deficient BTK mutants confer ibrutinib resistance through activation of the kinase HCK

Science Signaling, 2022
Kamaldeep Dhami, Anirban Chakraborty, T. Gururaja, L. Cheung, Chaohong Sun, F. Deanda, Xiaodong Huang   +6 more
semanticscholar   +1 more source

T‐Cell–Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma: Current Evidence, Sequencing, and Future Directions

European Journal of Haematology, Volume 116, Issue 2, Page 129-141, February 2026.
ABSTRACT Relapsed/refractory (R/R) mantle cell lymphoma (MCL) remains a therapeutic challenge, particularly in patients with high‐risk features or prior exposure to Bruton's tyrosine kinase inhibitors (BTKis). The advent of T‐cell–redirecting immunotherapies, including chimeric antigen receptor T‐cell (CAR‐T) therapy and bispecific antibodies (BsAbs ...
Santino Caserta, Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Fortunato Morabito, Massimo Gentile   +10 more
wiley   +1 more source

Tüskés Gábor: Hagyomány és kritika, Könyvek, könyvbírálatok a kora újkori európai irodalom és művelődés történetéhez. Budapest, MTA BTK, 2013, 279 l. [PDF]

, 2015
István Monok
openalex  

A mohácsi csata egy új képe – az MTA BTK Történettudományi Intézet egy új tanulmánykötete kapcsán

, 2019
Gábor Farkas Farkas
openalex   +2 more sources

Development of a Model for Chemical Screening Based on Collateral Sensitivity to Target BTK C481S Mutant [PDF]

, 2020
Camille Libre, Ludovic Moro-Sibilot, Stéphane Giraud, Laetitia B. B. Martin, Els Verhoeyen, Caroline Costa, Amel Chebel, Nathalie Bissay, Gilles Salles, Laurent Genestier, Pierre Sujobert   +10 more
openalex   +1 more source